Skip to main navigation menu Skip to main content Skip to site footer

Saggi

No. 133 (2025)

Cardiovascular Risk Prevention and Connected Health Services: The Interplay between the Technology Market and Public Health

DOI
https://doi.org/10.3280/mesa2025-133oa21508
Submitted
novembre 28, 2025
Published
2026-02-18

Abstract

ICTs are being increasingly utilised in the healthcare sector to enhance service efficiency and patient care through digital medicine and connected healthcare tools. This research aimed to determine the perception of users and whether investing in digital healthcare services is worthwhile.
This research aimed to answer these and other questions with a questionnaire addressed to a large sample of potential users of a cardiovascular risk prevention service in ‘Connected Health’.
The research results can serve as a reference for those interested in developing business models for digital health services, whether in the private sector or within the National Health Service.
Additionally, they can be used to evaluate the political priorities outlined in the M6C1 of the PNRR for improving the healthcare system.

References

  1. Alarabyat I. A., Al-Nsair N., Alrimawi I., Al-Yateem N., Shudifat R. M., & Saifan A. R. (2023). Perceived barriers to effective use of telehealth in managing the care of patients with cardiovascular diseases: a qualitative study exploring healthcare professionals’ views in Jordan. BMC health services research, 23(1), 452.
  2. Anitec-Assinform (2024). Il Digitale in Italia 2024, vol. I (luglio). – https://www.anitec-assinform.it/kdocs/2119291/il_digitale_in_italia_2023_v3.pdf (URL consultato 02/02/2024).
  3. Anitec-Assinform White Paper (2023), Una visione di futuro per la sanità digitale. Innovazione e benessere viste dalle aziende ICT, (novembre). – https://www.anitec-assinform.it/kdocs/2110774/wp3_gdlsan_071123_corretto.pdf (URL consultato 02/02/2024).
  4. Battineni G., Sagaro G. G., Chintalapudi N., & Amenta F. (2021). The benefits of telemedicine in personalized prevention of cardiovascular diseases (CVD): A systematic review. Journal of Personalized Medicine, 11(7), 658.
  5. Borgonovi E., Migliore G. (2022). Digitalizzazione della sanità o sanità digitale?. Mecosan – Management Ed Economia Sanitaria – Open Access, (123). DOI: 10.3280/mesa2022-123oa15579.
  6. Breidert C., Hahsler M., & Reutterer T. (2006). A review of methods for measuring willingness-to-pay. Innovative marketing, 2(4).
  7. Brunton L, Bower P, Sanders C. (2015). The Contradictions of Telehealth User Experience in Chronic Obstructive Pulmonary Disease (COPD): A Qualitative Meta-Synthesis. PLoS One. Oct 14, 10(10), e0139561. DOI: 10.1371/journal.pone.0139561.
  8. Delvecchio F. (2024). Statistica per lo studio dei fenomeni sociali, II ed. Padova: Cleup.
  9. Gentili A., Failla G., Melnyk A., Puleo V., Tanna G. L. D., Ricciardi W., & Cascini F. (2022). The cost-effectiveness of digital health interventions: a systematic review of the literature. Frontiers in Public Health, 10, 787135.
  10. Gauthier C, Bastianutti J, Haggège M. (2018). Managerial capabilities to address digital business models: The case of digital health. Strategic Change, 27: 173-180. DOI: 10.1002/jsc.2192.
  11. Jiang X., Ming W. K., & You J. H. (2019). The cost-effectiveness of digital health interventions on the management of cardiovascular diseases: systematic review. Journal of medical Internet research, 21(6), e13166.
  12. Kish L. (1992). Weighting for unequal Pi. Journal of Official Statistics, 8(2): 183-200.
  13. Kraus S., Schiavone F., Pluzhnikova A., Invernizzi A.C. (2021). Digital transformation in healthcare: Analyzing the current state-of-research, Journal of Business Research, 123: 557-567. DOI: 10.1016/j.jbusres.2020.10.030.
  14. Longo F, Guerra F., Zazzera A. (2022). La trasformazione dell’assistenza territoriale e gli spazi di autonomia locali: quali variabili strategiche?. Mecosan – Management Ed Economia Sanitaria – Open Access, (123). DOI: 10.3280/mesa2022-123oa15581.
  15. Lupton D. (2014). Critical Perspectives on Digital Health Technologies, Sociology Compass, 8: 1344-1359. DOI: 10.1111/soc4.12226.
  16. Ministero della salute (2014). Telemedicina. Linee di indirizzo nazionali. Roma.
  17. Ministero della salute (2020). Indicazioni nazionali per l’erogazione di prestazioni di telemedicina. Roma.
  18. Ministero della salute (2022). D.M. 21 settembre 2022, Approvazione delle linee guida per i servizi di telemedicina – Requisiti funzionali e livelli di servizio. Roma.
  19. Ministero della Salute (2016). Piano Nazionale della cronicità, Accordo tra lo Stato, le Regioni e le Province Autonome di Trento e di Bolzano, 15 settembre 2016. Roma.
  20. Papi G., Ricci F. L. (2000). La telemedicina, ICAR-CNR. – https://didattica-2000.archived.uniroma2.it/fam/deposito/Telemedicina.pdf (URL consultato 02/02/2024).
  21. Park L. G., Beatty A., Stafford Z., & Whooley M. A. (2016). Mobile phone interventions for the secondary prevention of cardiovascular disease. Progress in cardiovascular diseases, 58(6): 639-650.
  22. Parretti C., La Regina M., Tortu C., Candido G., Tartaglia R. (2022). Telemedicine in Italy, the starting point. Internal and Emergency Medicine, 18: 949-951 (2023). DOI: 10.1007/s11739-022-03176-6.
  23. Paul D.L., McDaniel R.R. (2016). Facilitating telemedicine project sustainability in medically underserved areas: a healthcare provider participant perspective. BMC Health Services Research, 16: 148. DOI: 10.1186/s12913-016-1401-y.
  24. Piette J. D., List J., Rana G. K., Townsend W., Striplin D., & Heisler M. (2015). Mobile health devices as tools for worldwide cardiovascular risk reduction and disease management. Circulation, 132(21): 2012-2027.
  25. Pirisi L, Reginato E. (2022). La digitalizzazione a supporto del processo di implementazione del nuovo modello di assistenza territoriale della ASL di Sassari. Mecosan – Management Ed Economia Sanitaria – Open Access, (123): 149-165. DOI: 10.3280/mesa2022-123oa15599.
  26. Qi Y., Mohamad E., Azlan A. A., Zhang C., Ma Y., & Wu A. (2025). Digital Health Solutions for Cardiovascular Disease Prevention: Systematic Review. Journal of Medical Internet Research, 27, e64981.
  27. Rossi Mori A. (2014). L’Innovazione tecnologica nell’assistenza territoriale. Rivista elettronica di Diritto, Economia, Management, V(3): 116-130.
  28. Santoni V. (2018). Gli investimenti, le opportunità e i rischi della digital health nel campo del welfare aziendale. Politiche Sociali, 2 (maggio/agosto): 217-234, DOI: 10.7389/90595.
  29. Singh A., Mountjoy N., McElroy D., Mittal S., Al Hemyari B., Coffey N., ... & Gaines K. (2021). Patient perspectives with telehealth visits in cardiology during COVID-19: online patient survey study. JMIR cardio, 5(1), e25074.
  30. Slevin P., Kessie T., Cullen J., Butler M. W., Donnelly S. C., Caulfield B. (2019). Exploring the potential benefits of digital health technology for the management of COPD: a qualitative study of patient perceptions. ERJ Open Research, 5(2): 00239-2018. DOI: 10.1183/23120541.00239-2018.
  31. Whitelaw S., Pellegrini D. M., Mamas M. A., Cowie M., & Van Spall H. G. (2021). Barriers and facilitators of the uptake of digital health technology in cardiovascular care: a systematic scoping review, European Heart Journal-Digital Health, 2(1): 62-74.